ABL Bio secures FDA Fast Track for gastric cancer therapy
--------------------------------------------------------------------
Source: The Korea Herald
Published: 2026-06-17 12:17 UTC+10:00
Section: All News
Factuality Score: 100
Opinion Category: Neutral
Topics: Health, Elections, Food & Agriculture, Drugs, World News
--------------------------------------------------------------------
Snippet:
ABL Bio said Wednesday that the US Food and Drug Administration granted Fast Track designation to Givastomig (ABL111), its gastric cancer treatment candidate being jointly developed with NovaRock Biotherapeutics.
--------------------------------------------------------------------